1.0% IP-001 for injection Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Louisville, Kentucky1 trial

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

University of Louisville

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.